P3.02c-046 Safety, Clinical Activity and Biomarker Results from a Phase Ib Study of Erlotinib plus Atezolizumab in Advanced NSCLC
Year: 2017
Type: article
Study design: Clinical Trial
Source: Journal of Thoracic Oncology
Authors: Charles Rudin, Andrés Cervantes, Afshin Dowlati, Benjamin Besse, Brigette Ma, Daniel Costa, Peter Schmid, Rebecca Heist, Victoria Villaflor, Indrani Sarkar, Mahrukh Huseni, Paul Foster, Carol O'Hear, Scott Gettinger
Institutions: Memorial Sloan Kettering Cancer Center, Universitat de València, University Hospitals Cleveland Medical Center, Chinese University of Hong Kong, Beth Israel Deaconess Medical Center, Barts Cancer Institute, Massachusetts General Hospital, Northwestern University, Genentech, Yale Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2570717541